Related references
Note: Only part of the references are listed.Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review
Brian E. Grunau et al.
Canadian Journal of Emergency Medicine (2016)
MDMA and temperature: A review of the thermal effects of 'Ecstasy' in humans
A. C. Parrott
DRUG AND ALCOHOL DEPENDENCE (2012)
Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
Cedric M. Hysek et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
A Perhaps Unexpected Role of Norepinephrine in Actions of MDMA
T. F. Newton
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (Ecstasy) in Humans
C. M. Hysek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions
Pinchas Halpern et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2011)
Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
Benjamin Di Cara et al.
JOURNAL OF NEUROSCIENCE (2011)
The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives
J. R. Docherty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Effects of a β-blocker on the cardiovascular response to MDMA (Ecstasy)
C. M. Hysek et al.
EMERGENCY MEDICINE JOURNAL (2010)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
Erich Studerus et al.
PLOS ONE (2010)
Norepinephrine and stimulant addiction
Mehmet Sofuoglu et al.
ADDICTION BIOLOGY (2009)
Cannabis Coadministration Potentiates the Effects of Ecstasy on Heart Rate and Temperature in Humans
G. J. Dumont et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
Mehmet Sofuoglu et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2009)
Cocaine and β-blockers:: Should the controversy continue?
Robert S. Hoffman
ANNALS OF EMERGENCY MEDICINE (2008)
Role of α1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse
S. Bexis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
alpha(1)-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access
Sunmee Wee et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration
Erin A. Kolbrich et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
The consequences of 3.4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans
Brian O'Mathuna et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: Prospective neuroendocrine and psychobiological changes
A. C. Parrott et al.
NEUROPSYCHOBIOLOGY (2008)
Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats
Katsutoshi Shioda et al.
NEUROTOXICOLOGY (2008)
Pharmacological interaction between 3,4-methylenedioxymethamphetamine (Ecstasy) and paroxetine:: Pharmacological effects and pharmacokinetics
Magi Farre et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Does hyperthyroidism increase risk of death due to the ingestion of ecstasy?
Teri L. Martin et al.
JOURNAL OF FORENSIC SCIENCES (2007)
α1-adrenergic receptors mediate the locomotor response to systemic administration of (±)-3,4-methylenedioxymethamphetamine (MDMA) in rats
Jennifer Selken et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment
Christopher D. Verrico et al.
PSYCHOPHARMACOLOGY (2007)
Roles of norepinephrine, free fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis
Jon E. Sprague et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Characterization of β-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein
I Bachmakov et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
GJH Dumont et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management
AP Hall et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
RR Freedman et al.
PSYCHOPHARMACOLOGY (2005)
Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model
JE Sprague et al.
CRITICAL CARE MEDICINE (2005)
The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis
DE Rusyniak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain
Philip H. Elsinga et al.
MOLECULAR IMAGING AND BIOLOGY (2005)
Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice
WE Fantegrossi et al.
PSYCHOPHARMACOLOGY (2004)
The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine
EM Mills et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Dantrolene use in 3,4-methylenedioxymethamphetamine (Ecstasy)-Mediated hyperthermia
DE Rusyniak et al.
ANESTHESIOLOGY (2004)
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with α1- plus β3-adrenoreceptor antagonists
JE Sprague et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia
JE Sprague et al.
BIOCHEMICAL PHARMACOLOGY (2004)
On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization
LJMJ Vanderschuren et al.
PSYCHOPHARMACOLOGY (2003)
Cocaine-induced hypophagia and hyperlocomotion in rats are attenuated by prazosin
P Wellman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase
TL White et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies
ME Liechti et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2001)
Gender differences in the subjective effects of MDMA
ME Liechti et al.
PSYCHOPHARMACOLOGY (2001)
Effect of fluoxetine on carvedilol pharmacokinetics, CYP2D6 activity, and autonomic balance in heart failure patients
DW Graff et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Psychological and physiological effects of MDMA (ecstasy) after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans
ME Liechti et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Acute psychological and physiological effects of MDMA (Ecstasy) after haloperidol pretreatment in healthy humans
ME Liechti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2000)
Effects of labetalol treatment on the physiological and subjective response to smoked cocaine
M Sofuoglu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
The symptom check-list-90-R (SCL-90-R): A German validation study
N Schmitz et al.
QUALITY OF LIFE RESEARCH (2000)
Share Paper
